Search Results for "Lunacalcipol Psoriasis"
Original Source: Cytochroma Inc
Cytochroma Inc. is an integrated specialty pharmaceutical company engaged in the development and commercialization of proprietary products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. The company has an advanced portfolio of new products targeting vitamin D deficiency and secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease and end-stage renal disease. In addition, the company is developing novel vitamin D thera...
Matching Channels
Psoriasis and Scaling Diseases
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the rep...
Technical Background Tumor necrosis factor (TNF) is a substance made by your body's immune system. People with inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, psoriatic a...
The interaction of complement C5a and its receptor for the treatment of inflammatory diseases include rheumatoid arthritis, systemic lupus erythematosus, asthma, wet age-related macular degeneration...
Tumor Necrosis Factor TNF Products
Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...
Matching News
Cytochroma, MTPC terminate lunacalcipol licensing agreement
Cytochroma has announced termination of a license agreement with Mitsubishi Tanabe Pharma (MTPC) thereby regaining rights to all indications of lunacalcipol indications in the US and in Asian territor...
Mitsubishi Tanabe and Cytochroma call time on lunacalcipol alliance
Mitsubishi Tanabe Pharma (MTP) and the Canadian firm Cytochroma have decided by mutual consent to end a licensing deal for Cytochroma's vitamin D hormone analogue lunacalcipol (CTA018/MT-2832). The...
Psoriasis Awareness Month: Psoriasis isn’t contagious but awareness is!
Each August, the National Psoriasis Foundation (NPF) sponsors Psoriasis Awareness Month, dedicated to raising awareness, educating the public and dispelling myths about the disease. What is psoriasis?...
Cytochroma Regains Rights to Lunacalcipol
MARKHAM, ON, June 1, 2012 /PRNewswire/ - Cytochroma today announced that it has regained the rights to all indications in the United States (US) and in Asian territories to lunacalcipol (previously...
August is Psoriasis Awareness Month: Psoriasis isn’t contagious but awareness is!
Each August, the National Psoriasis Foundation (NPF) sponsors Psoriasis Awareness Month, dedicated to raising awareness, educating the public and dispelling myths about the disease. What is psoriasis?...
Seattle, Wa (PRWEB) April 01, 2013 Psoriasis Free For Life is an effective method made by Katy Wilson, who promises to give home remedies for psoriasis that can help people treat psoriasis perman...
Seattle, WA (PRWEB) December 31, 2012 The creator of Psoriasis Free For Life is Katy Wilson, who is an alternative Medical practitioner and researcher. She suffered from psoriasis 15 years ago. S...
Psoriasis patients use social networks. Here’s why you should care.
What do psoriasis patients discuss online? Brian Loew explores, and highlights the significance of these conversations with regards to the healthcare industry. About 8 in 10 psoriasis patients who us...
Matching PubMed Articles
Clinical and Histologic Diagnostic Guidelines for Psoriasis: A Critical Review.
Psoriasis is a common inflammatory skin disease that is associated with joint, psychiatric, and cardiovascular comorbidities. Diagnosis of plaque psoriasis is dependent primarily on characteristic phy...
Psoriasis and uveitis: a literature review.
Psoriasis is a systemic, chronic, immunologically mediated disease, with significant genetic and environmental influences. It affects from 1 to 3% of the world population. Recently, the relation betwe...
Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation.
An association between obesity and psoriasis has been reported. For a variety of reasons, obese persons with psoriasis are often more difficult to treat. We sought to review the literature on obesity...
ADAM33 as a Psoriasis Susceptibility Gene in the Han Population of Northeastern China.
Background: A disintegrin and metalloprotease 33 (ADAM33) has recently been suspected to be associated with psoriasis. Objective:To study the association between ADAM33 and psoriasis in the northeaste...
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin.
Microorganisms have been implicated in the pathogenesis of psoriasis. Previous studies of psoriasis and normal skin have used swabs from the surface rather than skin biopsies. In this study, biopsies...
